top of page

Theme-based Research Scheme on Viral, Host and Environmental Determinants

Of Influenza Virus Transmission and Pathogenesis and Centre of Influenza Research Seminars, 8 April 2016

The Theme-based Research Scheme on Viral, Host and Environmental Determinants of Influenza Virus Transmission and Pathogenesis and the Centre of Influenza Research Seminars jointly organize the following serie of seminars:

Date: 8 April 2016 (Friday) Time: 11:00 am to 12:30 pm Venue: Mrs Chen Yang Foo Oi Telemedicine Centre, 2/F William MW Mong Block, LKS Faculty of Medicine , HKU

Seminar 1 “Case-control Study of Vaccine Effectiveness in Preventing Laboratory-confirmed Influenza Hospitalizations in Older Adults, United States, 2010-11” by Dr Fiona Havers, MD MHS Influenza Division, US CDC, Atlanta Biography: Fiona Havers, MD, MHS, is a Medical Officer for the Influenza Prevention and Control Team, Epidemiology and Prevention Branch, Influenza Division, within the U.S. CDC's National Center for Immunization and Respiratory Diseases. Dr. Havers earned a Doctor of Medicine from the University of Washington. She completed training in internal medicine and infectious diseases at the Johns Hopkins University. She also obtained a Master’s of Health Science in Epidemiology from the Johns Hopkins Bloomberg School of Public Health and completed the Epidemic Intelligence Service training in the Influenza Division at CDC. She is board certified to practice internal medicine and infectious diseases, and is a staff physician at the Atlanta VA Medical Center. While at CDC, Dr. Havers’ research interests have focused on the epidemiology, prevention and treatment of influenza. Her current primary research focuses on influenza antiviral treatment as well as influenza vaccine effectiveness. Seminar 2 “Increasing Seasonal Influenza Vaccination Coverage Among High Risk Groups in China: The Role of the Community Healthcare Worker” by Dr Carolyn Greene, MD Influenza Division, US CDC, Beijing Biography: In September 2014, Dr. Carolyn Greene joined the U.S. CDC China Office as Director of the Influenza Program. Prior to moving to Beijing, Dr. Greene served as Deputy Commissioner for the Division of Epidemiology in New York City’s Department of Health and Mental Hygiene and as medical epidemiologist at the Centers for Disease Control and Prevention, first in the Respiratory Diseases Branch and then within the Global AIDS Program in Ethiopia. Dr. Greene completed internal medicine residency at University of California at San Francisco, medical school at Brown University and undergraduate studies at Yale University. From 1990-1992, Dr. Greene taught English at Huazhong Normal University in Wuhan with the Yale-China Association. Currently, the US CDC influenza team in Beijing works closely with China CDC and other local partners to enhance prevention, detection and control of seasonal and novel influenza viruses in China. One priority is collecting local influenza disease burden and vaccine effectiveness data to promote seasonal influenza vaccination among young children, older adults, pregnant women and healthcare workers. Seminar 3 “Effects of Repeated Influenza Vaccination on Vaccine Effectiveness and Immunogenicity” by Dr Mark Thompson, PhD Influenza Division, US CDC, Atlanta Biography:

Mark Thompson, Ph.D. is an Epidemiologist in the Influenza Division of the US Centers for Disease Control and Prevention. He currently serves as Principal Investigator (PI) on multi-country investigations of influenza burden and vaccine effectiveness (VE), including studies focused on pregnant women, infants, older adults, and healthcare personnel; he previously served as PI for the US Flu VE Network. Mark received his doctorate in clinical and community psychology and completed post-doctoral fellowships in inter-disciplinary geriatric care and in statistics. Before joining CDC, he worked at Kaiser Permanente Northern California where he led clinical practice guideline initiatives and served as Program Director for Preventive Care. He has also spent time in the private sector developing information technologies and working with large employers (including Ford, General Motors, and AT&T) to improve disease management and preventive care for their employees. ALL are welcome. Kindly refer to for any queries.


bottom of page